
- Volume 0 0
Test Identifies Ovarian Cancer
John Hopkins researchers have developeda test to detect ovarian cancer byidentifying 3 proteins found in the bloodof women with the disease, according toan article reported in Cancer Research(August 15, 2004). Earlier studies withthe test suggested that there is a molecularsignature exclusive to ovarian cancer,which can remain undetected andspread quickly.
"By identifying a select group of biomarkersspecific to ovarian cancer, we notonly know the proteins we are dealingwith, but we can trace them back to alterationsin the genetic code of ovarian cancercells," said Daniel W. Chan, PhD,director of Biomarker Discovery Center atJohns Hopkins.
Additional studies are needed, however,before the test is commercially availablefor screening ovarian cancer. Chanpointed out that no blood test will be ableto correctly diagnose 100% of canceroustumors all the time.
Articles in this issue
over 21 years ago
Rural Pharmacy Chain Chooses ScriptPro Automationover 21 years ago
System Improves Productivity, Drug Verificationover 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Cardinal Introduces PatientPAK 340Bover 21 years ago
Obesity Is an Addiction, Researchers Sayover 21 years ago
Scientists Seek to Understand How Fat Causes Cancerover 21 years ago
Government Plans Attack on Obesityover 21 years ago
Gene Discovery May Unlock Key to Obesity Syndromeover 21 years ago
Consuming Fruit, Not Fat, Staves Off Weight GainNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.










































































































































































































